DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS










 Company News
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals 8/7/2014 7:41:19 AM
Study Published In The New England Journal of Medicine Finds Medtronic, Inc. (MDT) Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients Better Than Standard Care 6/26/2014 8:32:51 AM
AstraZeneca PLC (AZN) Release: Data Published In The New England Journal of Medicine Demonstrate Naloxegol Improved Opioid-Induced Constipation In Chronic Pain Patients 6/19/2014 12:58:41 PM
Two-Year Results From Pfizer Inc. (PFE)’s XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published In The New England Journal of Medicine 6/19/2014 11:20:11 AM
The Medicines Company (MDCO) Release: ORBACTIV™ (Oritavancin) Phase 3 Trial Results Published In The New England Journal of Medicine 6/5/2014 9:18:26 AM
The New England Journal of Medicine Publishes Data From Durata Therapeutics, Inc.  (DRTX)'s Discover Program 6/5/2014 9:09:16 AM
Medivation, Inc. (MDVN) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy 6/2/2014 10:46:45 AM
Astellas Pharma Inc. (ALPMY) Release: The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer 6/2/2014 10:14:25 AM
The New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naive Metastatic Prostate Cancer Progressing Despite Androgen Deprivation Therapy 6/2/2014 9:18:04 AM
Ethicon, Inc. (JNJ)-Funded Study Confirming Long-Term Benefit Of Bariatric Surgery For Control Of Diabetes Published In The New England Journal of Medicine 5/27/2014 10:27:43 AM
12345678910...